364 related articles for article (PubMed ID: 32882762)
1. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
Tian F; Ying HM; Wang YY; Cheng BN; Chen J
Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.
Cai H; Jiang Z; Yang X; Lin J; Cai Q; Li X
Endocr J; 2020 Apr; 67(4):397-408. PubMed ID: 31875589
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
4. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
[TBL] [Abstract][Full Text] [Related]
5. MiR-181c restrains nitration stress of endothelial cells in diabetic db/db mice through inhibiting the expression of FoxO1.
Yang G; Wu Y; Ye S
Biochem Biophys Res Commun; 2017 Apr; 486(1):29-35. PubMed ID: 28223216
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
7. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance.
Song Y; Wu L; Li M; Xiong X; Fang Z; Zhou J; Yan G; Chen X; Yang J; Li Y
EBioMedicine; 2019 Apr; 42():494-503. PubMed ID: 30948354
[TBL] [Abstract][Full Text] [Related]
8. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
[TBL] [Abstract][Full Text] [Related]
9. Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21/forkhead box O1 axis.
Wang J; Shen L; Hong H; Li J; Wang H; Li X
Eur J Pharmacol; 2019 Jun; 852():142-150. PubMed ID: 30876973
[TBL] [Abstract][Full Text] [Related]
10. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CTBP1-AS2 alleviates high glucose-induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p/FOXO1 axis.
Wang G; Wu B; Zhang B; Wang K; Wang H
Biochem Biophys Res Commun; 2020 Nov; 532(2):308-314. PubMed ID: 32868076
[TBL] [Abstract][Full Text] [Related]
12. Enhanced alleviation of insulin resistance via the IRS-1/Akt/FOXO1 pathway by combining quercetin and EGCG and involving miR-27a-3p and miR-96-5p.
Liu H; Guan H; Tan X; Jiang Y; Li F; Sun-Waterhouse D; Li D
Free Radic Biol Med; 2022 Mar; 181():105-117. PubMed ID: 35124182
[TBL] [Abstract][Full Text] [Related]
13. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
[TBL] [Abstract][Full Text] [Related]
14. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
Cho HM; Seok YM; Lee HA; Song M; Kim I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-532-5p is implicated in the regulation of osteoporosis by forkhead box O1 and osteoblast differentiation.
Guo X; Wei S; Xu F; Cai X; Wang H; Ding R
BMC Musculoskelet Disord; 2020 May; 21(1):296. PubMed ID: 32404197
[TBL] [Abstract][Full Text] [Related]
16. N
Zhang J; Chen Y; Liu C; Li L; Li P
J Diabetes Res; 2020; 2020():1080152. PubMed ID: 32280711
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
19. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting FOXO1.
Han C; Mo K; Jiang L; Wang K; Teng L
Mol Cell Biochem; 2022 Apr; 477(4):1195-1206. PubMed ID: 35084673
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.
Yan C; Li J; Feng S; Li Y; Tan L
Cell Death Dis; 2018 Feb; 9(3):289. PubMed ID: 29459686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
